Amway published study on botanical inhibition of inflammatory mediators
Amway has published a study examining a botanical substance's ability to selectively inhibit inflammatory mediators based on genotype. The research presents a proof of concept for nutrigenetics.
Amway has released a scientific study detailing the effects of a botanical substance on inflammatory mediators. Published in the journal Nutrition on September 20, 2007, the paper introduces the principles of nutrigenetics and provides a proof of concept for its application.
The research focuses on the relationship between interleukin-1 (IL-1) genotypes and inflammatory mediators. It demonstrates how a botanical compound can selectively inhibit specific inflammatory responses, depending on an individual's genetic makeup. This finding opens avenues for developing personalized nutritional strategies and health support informed by genetic data.
Amway aims to advance the understanding of how nutrition and genetics interact within the human body. This publication signifies the company's commitment to supporting scientific inquiry and translating research into potential product development. The outcomes could inform the creation of more precise and individualized dietary supplements.
This study represents a significant contribution to the field of nutrigenetics, bridging nutritional science and genetics. It lays a foundation for future investigations and the development of nutritional products that more accurately account for individual genetic variations.